Ventipulmin Solution for Injection 30 micrograms/ml

País: Regne Unit

Idioma: anglès

Font: VMD (Veterinary Medicines Directorate)

ingredients actius:

Clenbuterol Hydrochloride

Disponible des:

Boehringer Ingelheim Animal Health UK Ltd

Codi ATC:

QR03CC13

Designació comuna internacional (DCI):

Clenbuterol Hydrochloride

formulario farmacéutico:

Solution for injection

tipo de receta:

POM-V - Prescription Only Medicine – Veterinarian

Grupo terapéutico:

Horses

Área terapéutica:

Respiratory expectorant

Estat d'Autorització:

Authorized

Data d'autorització:

1994-08-22

Fitxa tècnica

Revised: November 2018
AN: 00958/2018
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Ventipulmin Solution for Injection 30 micrograms/ml
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
ACTIVE SUBSTANCE:
Clenbuterol hydrochloride 30 micrograms
Preservative:
Benzyl alcohol 10 mg/ml
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear colourless solution.
4. CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of respiratory disease in horses where it is considered that
airway obstruction due to bronchospasm and/or accumulation of mucus is
a contributing factor, and improved muco-ciliary clearance is
desirable. To
be used alone or as adjuvant therapy.
In particular:
i) Acute, sub-acute and chronic respiratory allergies.
ii) Acute, sub-acute and chronic infections where the presence of mucu
and/or micro-organisms may stimulate bronchospasm or cause airway
obstruction and thus an increase in airway resistance. For example;
bronchitis, bronchiolitis and bronchopneumonia alone, or associated
with
equine influenza and other viral respiratory diseases.
iii) Chronic Obstructive Pulmonary Disease (COPD).
In cases accompanied by bacterial infection the administration of
antimicrobial agents is recommended.
Revised: November 2018
AN: 00958/2018
Page 2 of 5
4.3
CONTRAINDICATIONS
None known.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Do not use in horses with known cardiac disease.
4.5
SPECIAL PRECAUTIONS FOR USE
Do not use in cases of known hypersensitivity to clenbuterol
i)
Special precautions for use in animals
None known.
ii)
Special precautions to be taken by the person administering the
veterinary medicinal product to animals.
This product contains clenbuterol, a

-agonist. Take care to avoid
skin contact. In case of skin contact wash affected area thoroughly.
If irritation occurs/persists seek medical advice. Take care to avoid
accidental eye contact. In